Download: Pfizer Regenerative Medicine presentation on cell therapy in big pharma
Natalie Mount, Executive Director, Development Lead at Pfizer Regenerative Medicine, presented at last year’s Stem Cells USA & Regenerative..
Lee Rubin, Principal Investigator and Director of Translational Medicine at Harvard Stem Cell Institute, presented at last year’s Stem Cells USA & Regenerative Medicine Congress on the topic, ‘Using stem cell-based..
Natalie Mount, Executive Director, Development Lead at Pfizer Regenerative Medicine, presented at last year’s Stem Cells USA & Regenerative..
David Bott, Director of Innovation Programs at the Technology Strategy Board UK, presented at last year’s Stem Cells USA & Regenerative..
HAIFA, ISRAEL, May 9, 2012 – Pluristem Therapeutics, Inc. (NASDAQCM:PSTI;TASE:PLTR) today announced that a seven year-old girl suffering from..
The World Stem cells & Regenerative Medicine Congress is less than 2 weeks away and we look forward to sharing the content with..
The Stem Cells USA & Regenerative Medicine Congress is back for its 4th consecutive year. As North America’s leading commercially-focused..
Gaining regulatory and market approval for your stem cell based therapy is merely one of the many challenges facing cell therapy developers...
Gary Rabin, CEO, Advanced Cell Technology explains the progress being made and the lessons learned as they commenced 2 human clinical trials..
Manufacturing and supplying a cell therapy throws up numerous challenges, especially when stem cell-based products need to be transported and..
Global annual revenues for the cell therapy industry have been growing, although having exceeded $1 billion, further growth is being constrained..
Each Gene Therapy has been searching for the perfect viral vector which will deliver a gene to the desired site without a negative interaction..
© terrapinn holdings ltd. MMX | images courtesy of SXC | terms & conditions | privacy | log in
